AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+36.7%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.37B
AUM Growth
+$4.37B
Cap. Flow
+$620M
Cap. Flow %
14.19%
Top 10 Hldgs %
43.92%
Holding
157
New
22
Increased
25
Reduced
24
Closed
21

Top Sells

1
BNTX icon
BioNTech
BNTX
$59.6M
2
BABA icon
Alibaba
BABA
$52.4M
3
MRNA icon
Moderna
MRNA
$26.1M
4
STNE icon
StoneCo
STNE
$21.2M
5
SRRK icon
Scholar Rock
SRRK
$19.2M

Sector Composition

1 Healthcare 82.45%
2 Consumer Discretionary 9.72%
3 Technology 2.14%
4 Communication Services 1.97%
5 Real Estate 1.41%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
XLI icon
126
Industrial Select Sector SPDR Fund
XLI
$23B
0
XLE icon
127
Energy Select Sector SPDR Fund
XLE
$27.1B
0
VXRT
128
DELISTED
Vaxart
VXRT
-750,000
Closed -$4.99M
STNE icon
129
StoneCo
STNE
$4.38B
-400,000
Closed -$21.2M
SLDB icon
130
Solid Biosciences
SLDB
$448M
-1,710,000
Closed -$3.47M
SLB icon
131
Schlumberger
SLB
$52.2B
0
RPRX icon
132
Royalty Pharma
RPRX
$15.8B
-250,000
Closed -$10.5M
RGNX icon
133
Regenxbio
RGNX
$498M
-222,300
Closed -$6.12M
QQQ icon
134
Invesco QQQ Trust
QQQ
$364B
0
PRTA icon
135
Prothena Corp
PRTA
$452M
-351,500
Closed -$3.51M
PMVP icon
136
PMV Pharmaceuticals
PMVP
$82.1M
-200,000
Closed -$7.1M
PASG icon
137
Passage Bio
PASG
$22.7M
-15,648
Closed -$205K
OXY icon
138
Occidental Petroleum
OXY
$45.6B
-375,000
Closed -$3.75M
NERV icon
139
Minerva Neurosciences
NERV
$16.8M
-760,000
Closed -$2.42M
MS icon
140
Morgan Stanley
MS
$237B
0
MRUS icon
141
Merus
MRUS
$5.04B
-250,000
Closed -$3M
JPM icon
142
JPMorgan Chase
JPM
$824B
0
IDYA icon
143
IDEAYA Biosciences
IDYA
$2.26B
-8
Closed
GS icon
144
Goldman Sachs
GS
$221B
0
GM icon
145
General Motors
GM
$55B
0
ESPR icon
146
Esperion Therapeutics
ESPR
$490M
-250,000
Closed -$9.29M
CTMX icon
147
CytomX Therapeutics
CTMX
$350M
-178,600
Closed -$1.19M
C icon
148
Citigroup
C
$175B
0
BMY icon
149
Bristol-Myers Squibb
BMY
$96.7B
0
BMRN icon
150
BioMarin Pharmaceuticals
BMRN
$11.3B
0